Marzieh Salehi MD MS
Diabetes, Lipid Metabolism
Professor of Medicine Department of Medicine, Diabetes Division, UT Health at San Antonio Medical Director, Bartter Clinical Research Unit, Audie Murphy Hospital, South Texas Veteran Health Care System
Join to View Full Profile
7703 Floyd Curl DriveSan Antonio, TX 78229
Phone+1 210-450-9490
Fax+1 210-450-6065
Dr. Salehi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board-certified endocrinologist with expertise as a clinician, translational researcher and educator in obesity, diabetes, and PCOS. My research focuses on the role of gut factors in glucose metabolism and energy balance in diabetes and obesity.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1998 - 2001
Tehran University of Medical Sciences School of MedicineClass of 1994
Certifications & Licensure
OH State Medical License 2004 - 2028
CA State Medical License 2015 - 2027
TX State Medical License 2018 - 2026
IL State Medical License 2003 - 2008
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
Clinical Trials
Publications & Presentations
PubMed
- Reduced prandial insulin secretion contributes to prandial hyperglycaemia in non-diabetic individuals with spinal cord injury.Michelle Trbovich, Sven Hoekstra, Amalia Gastaldelli, Marzieh Salehi
Diabetes, Obesity & Metabolism. 2025-09-01 - 2 citationsMesenteric Visceral Lipectomy Improves Glucose Tolerance in Patients With Type 2 Diabetes: A Pilot Study.Gozde Baskoy, Richard M Peterson, Jason Kempenich, Curtis Triplitt, Marissa Brown
The Journal of Clinical Endocrinology and Metabolism. 2025-08-07 - GLP-1 enhances β-cell response to protein ingestion and bariatric surgery amplifies it.Maria Rayas, Samantha Pezzica, Henri Honka, Fabrizia Carli, Richard Peterson
Obesity. 2025-01-01
Press Mentions
UT Health San Antonio Leads $4 Million Study on Glucagon’s Role in Diabetes, ObesityNovember 11th, 2025
Cause for Exaggerated Insulin Response in Subset of Bariatric Surgery Patients IdentifiedMarch 27th, 2014
Health News - Hormone Action Likely Culprit of Hypoglycemia After Gastric Bypass SurgeryFebruary 10th, 2016
Grant Support
- Glucagon-mediated glycemic effect in humans with and without rerouted gut after bariatric surgeryUNIVERSITY OF TEXAS HLTH SCIENCE CENTER2025–2030
- Glycemic and Weight Loss Effects of Semaglutide in Subjects After Spinal Cord Injury and Type 2 DiabetesUNIVERSITY OF TEXAS HLTH SCIENCE CENTER2024–2028
- Hormonal And Neural Control Of Insulin Secretion Following Gastric Bypass SurgeryNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Role Of Glp1 In Glucose MetabolismNational Center For Research Resources2008
Professional Memberships
- Member
- Member
- Member
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
